Sickle Cell Disease Drug approved in EU to interfere with Pathogenesis

被引：0
|
作者：
Freye, Reimund
机构：
来源：
ACTA HAEMATOLOGICA | 2022年 / 145卷 / 05期
关键词：
BRENTUXIMAB VEDOTIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：573 / 573
页数：1
相关论文
共 50 条
  • [11] First Cell-Based Gene Therapy Approved for Sickle Cell Disease
    Roush, Karen
    AMERICAN JOURNAL OF NURSING, 2024, 124 (03) : 10 - 10
  • [12] Role of the coagulation system in the pathogenesis of sickle cell disease
    Nasimuzzaman, Md
    Malik, Punam
    BLOOD ADVANCES, 2019, 3 (20) : 3170 - 3180
  • [13] Clues to pathogenesis of fibromyalgia in patients with sickle cell disease
    Schlesinger, N
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (03) : 598 - 600
  • [14] Role of oxidative stress in the pathogenesis of sickle cell disease
    Chirico, Erica N.
    Pialoux, Vincent
    IUBMB LIFE, 2012, 64 (01) : 72 - 80
  • [15] Cardiorespiratory pathogenesis of sickle cell disease in a mouse model
    Ren, Jun
    Ding, Xiuqing
    Trudel, Marie
    Greer, John J.
    MacLean, Joanna E.
    SCIENTIFIC REPORTS, 2017, 7
  • [16] Cardiorespiratory pathogenesis of sickle cell disease in a mouse model
    Jun Ren
    Xiuqing Ding
    Marie Trudel
    John J. Greer
    Joanna E. MacLean
    Scientific Reports, 7
  • [17] Adakveo for sickle cell disease off the market in the EU
    Reactions Weekly, 2023, 1960 (1) : 1 - 1
  • [18] L-Glutamine approved for use in patients with sickle cell disease
    Ali, Syed Ibaad
    Akhter, Rimsha
    Khan, Ariba
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (03) : 507 - 507
  • [19] Hydroxyurea in Sickle Cell Disease: Drug Review
    Rohit Kumar Agrawal
    Rakesh Kantilal Patel
    Varsha shah
    Lalit Nainiwal
    Bhadra Trivedi
    Indian Journal of Hematology and Blood Transfusion, 2014, 30 : 91 - 96
  • [20] SICKLE-CELL DISEASE AND DRUG DEVELOPMENT
    PETERSON, CM
    DRUG THERAPY HOSPITAL EDITION, 1978, 3 (08): : 6 - 7
12345